Mind Medicine MindMed(MNMD.US)

Last Updated 19:00:00 ET
longbridge loading

FDA Moves To Fast-Track Psychedelic Therapies For Mental Health

rttnews·
US
ATAI
+3.28%
US
CYBN
0.00%
US
MNMD
0.00%
rttnews·
US
ATAI
+3.28%
US
CYBN
0.00%
US
MNMD
0.00%

Trump Order To Accelerate Treatments For Serious Mental Illness

rttnews·
US
CMPS
+7.94%
US
MNMD
0.00%
US
PSIL
+3.15%
rttnews·
US
CMPS
+7.94%
US
MNMD
0.00%
US
PSIL
+3.15%

Trump: Accelerate access to research on psychedelic drugs

Wallstreetcn·
US
GHRS
+2.73%
US
MNMD
0.00%
US
ATAI
+3.28%
Wallstreetcn·
US
GHRS
+2.73%
US
MNMD
0.00%
US
ATAI
+3.28%

Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything.

businessinsider·
US
MNMD
0.00%
US
FBT
+2.14%
US
IBB
+2.27%
businessinsider·
US
MNMD
0.00%
US
FBT
+2.14%
US
IBB
+2.27%

11:03 ETSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems

prnewswire·
US
SOND
0.00%
US
BBH
+0.96%
US
LABU
+11.76%
prnewswire·
US
SOND
0.00%
US
BBH
+0.96%
US
LABU
+11.76%

NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

The newswire.ca·
US
PBE
+1.60%
US
XBI
+3.88%
US
CMND
+6.64%
The newswire.ca·
US
PBE
+1.60%
US
XBI
+3.88%
US
CMND
+6.64%

MedWellAI, Inc. SEC 10-Q Report

TradingView·
US
IHE
+0.84%
US
IBBQ
+2.43%
US
FBT
+2.14%
TradingView·
US
IHE
+0.84%
US
IBBQ
+2.43%
US
FBT
+2.14%

Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial | CMND Stock News

StockTitan·
US
PBE
+1.60%
US
IXJ
+0.35%
US
PRME
+4.81%
StockTitan·
US
PBE
+1.60%
US
IXJ
+0.35%
US
PRME
+4.81%

Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.

Unusual Whales·
US
IXJ
+0.35%
US
XBI
+3.88%
US
BBH
+0.96%
Unusual Whales·
US
IXJ
+0.35%
US
XBI
+3.88%
US
BBH
+0.96%
© 2026 Longbridge｜Disclaimer